TITLE

Medical promise or moral poison?

AUTHOR(S)
McGovern, Celeste
PUB. DATE
October 2000
SOURCE
Report / Newsmagazine (Alberta Edition);10/09/2000, Vol. 27 Issue 11, p42
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the debate over human embryo stem cell research. Mention of the United States Stem Cell Research Act of 2000; Morality of using embryos for research purposes; Possibility that adult stem cells can be used in the same way as embryonic cells; Practice of tissue engineering in Great Britain, which involves the growing of human organs from the patient's own cells. INSET: Banking on cord blood.
ACCESSION #
3650319

Tags: EMBRYONIC stem cells -- Moral & ethical aspects;  STEM cells -- Government policy;  HUMAN embryo;  CYTOLOGY -- Research -- Government policy

 

Related Articles

  • Medical promise or moral poison? McGovern, Celeste // Report / Newsmagazine (National Edition);10/09/2000, Vol. 27 Issue 11, p42 

    Focuses on the debate over human embryo stem cell research. Mention of the United States Stem Cell Research Act of 2000; Morality of using embryos for research purposes; Possibility that adult stem cells can be used in the same way as embryonic cells; Practice of tissue engineering in Great...

  • Medical promise or moral poison? McGovern, Celeste // Report / Newsmagazine (BC Edition);10/09/2000, Vol. 27 Issue 11, p42 

    Focuses on the debate over human embryo stem cell research. Mention of the United States Stem Cell Research Act of 2000; Morality of using embryos for research purposes; Possibility that adult stem cells can be used in the same way as embryonic cells; Practice of tissue engineering in Great...

  • Embryonic Stem cell research - The case for... Winston, Robert // Nature Medicine;Apr2001, Vol. 7 Issue 4, p396 

    Defends the approval of research in the use of embryonic stem (ES) cells by the British government. Reason for provision of legislative support to ES cell research; Questions to be addressed regarding the morality behind stem cell therapy; Comment of the author on the purpose of cloning...

  • Blow to German stem-cell prospects. Abbott, Alison // Nature;11/15/2001, Vol. 414 Issue 6861, p238 

    Focuses on the research on human embryonic stem cells in Germany. Closure on the legalization of the human ES cells importation; Deliberations over the embryonic cells approbation; Regulations on the importation of the human ES cells under the National Ethics Council.

  • A DEBATE THAT STEMS FROM HUMAN CELLS. Munro, Neil // National Journal;5/26/2001, Vol. 33 Issue 21, p1587 

    Examines the issues surrounding human stem cell research in the United States. Potential therapeutic use of stem cells; Argument of stem cell research advocates that federal funding is needed for the advancement of stem cell research; Ethical issues related to the therapeutic use of stem...

  • US government to fund human stem cell research. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);09/02/2000, Vol. 321 Issue 7260, p527 

    Reports on the announcement that the United States government will fund medical research using human embryo stem cells. Advantages of the use of such cells in medical research; Opposition of anti-abortion activists and others to the decision, which they view as immoral; Guidelines for the use...

  • Netherlands bans cloning of human embryos for research. Sheldon, Tony // BMJ: British Medical Journal (International Edition);10/07/2000, Vol. 321 Issue 7265, p852 

    Reports on the proposal of the Dutch government to ban medical research involving the therapeutic cloning of human embryos. Provisions of the proposed ban; Public opinion regarding genetic research in the Netherlands.

  • Patent Watch.  // Nature Reviews Drug Discovery;Jan2009, Vol. 8 Issue 1, p12 

    The article reports on the decision of the highest board of appeal of the European Patent Office (EPO) that the European patent law disallows the patenting of stem cells that involve destruction of human embryos. The appeal was initiated following the EPO rejection of the patent application of...

  • In Support of Stem Cells. Lemonick, Michael D.; Thompson, Dick // Time;9/4/2000, Vol. 156 Issue 10, p58 

    Reports that under guidelines issued by the United States National Institutes of Health, government-funded scientists can use early-stage embryos left over from in-vitro fertilizations for research. Requirement that harvesting must be done by private firms; Potential of embryonic stem cells for...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics